NONLINEAR ASSESSMENT OF PHENYTOIN BIOAVAILABILITY

被引:102
作者
JUSKO, WJ
KOUP, JR
ALVAN, G
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT PHARM,BUFFALO,NY 14214
[2] HUDDINGE UNIV HOSP,DEPT CLIN PHARMACOL,HUDDINGE,SWEDEN
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1976年 / 4卷 / 04期
关键词
D O I
10.1007/BF01063122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:327 / 336
页数:10
相关论文
共 12 条
  • [1] ALBERT KS, 1974, CLIN PHARMACOL THER, V16, P727
  • [2] GARRETTSON LK, 1975, CLIN PHARMACOL THER, V17, P481
  • [3] GERBER N, 1972, RES COMMUN CHEM PATH, V3, P455
  • [4] GLAZKO AJ, 1972, ANTIEPILEPTIC DRUGS, P127
  • [5] GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135
  • [6] KOSTENBAUDER HB, 1975, CLIN PHARMACOL THER, V18, P449
  • [7] BIOAVAILABILITY, CLINICAL EFFECTIVENESS, AND PUBLIC INTEREST
    LEVY, G
    [J]. PHARMACOLOGY, 1972, 8 (1-3) : 33 - 43
  • [8] PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF PHENYTOIN IN MAN
    LUND, L
    ALVAN, G
    BERLIN, A
    ALEXANDERSON, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) : 81 - 86
  • [9] BIOAVAILABILITY CALCULATIONS FOR DRUGS SHOWING SIMULTANEOUS FIRST-ORDER AND CAPACITY-LIMITED ELIMINATION KINETICS
    MARTIS, L
    LEVY, RH
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (04): : 283 - 294
  • [10] PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTS
    MAWER, GE
    MULLEN, PW
    RODGERS, M
    ROBINS, AJ
    LUCAS, SB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) : 163 - 168